PMID- 22174393 OWN - NLM STAT- MEDLINE DCOM- 20120911 LR - 20161125 IS - 1522-1601 (Electronic) IS - 0161-7567 (Linking) VI - 112 IP - 5 DP - 2012 Mar TI - Nitric oxide modulates hypoxia-inducible factor-1 and poly(ADP-ribose) polymerase-1 cross talk in response to hypobaric hypoxia. PG - 816-23 LID - 10.1152/japplphysiol.00898.2011 [doi] AB - The physiological response to hypobaric hypoxia represents a complex network of biochemical pathways in which the nitrergic system plays an important role. Previous studies have provided evidence for an interplay between the hypoxia-inducible factor-1 (HIF-1) and poly(ADP-ribose) polymerase-1 (PARP-1) under hypoxia. Here, we evaluate the potential involvement of nitric oxide (NO) in the cross talk between these two proteins. With this aim, we studied comparatively the effect of pharmacological inhibitors of NO production or PARP activity in the response of the mouse cerebral cortex to 4 h of exposure to a simulated altitude of 31,000 ft. Particularly, we analyzed the NO and reactive oxygen species production, the expression of NO synthase (NOS) isoforms, PARP-1 activity, HIF-1alpha expression and HIF-1 transcriptional activity, the protein level of the factor inhibiting HIF, and, finally, beclin-1 and fractin expression, as markers of cellular damage. Our results demonstrate that the reduction of NO level did not affect reactive oxygen species production but significantly 1) dampened the posthypoxic increase in neuronal NOS and inducible NOS expression without altering endothelial NOS protein level; 2) prevented PARP activation; 3) decreased HIF-1alpha response to hypoxia; 4) achieved a higher long-term HIF-1 transcriptional activity by reducing factor inhibiting HIF expression; and 5) reduced hypoxic damage. The pharmacological inhibition of PARP reproduced the NOS expression pattern and the HIF-1alpha response observed in NOS-inhibited mice, supporting its involvement in the NO-dependent regulation of hypoxia. As a whole, these results provide new data about the molecular mechanism underlying the beneficial effects of controlling NO production under hypobaric hypoxic conditions. FAU - Martinez-Romero, Ruben AU - Martinez-Romero R AD - Department of Experimental Biology, University of Jaen, Jaen, Spain. FAU - Canuelo, Ana AU - Canuelo A FAU - Siles, Eva AU - Siles E FAU - Oliver, F Javier AU - Oliver FJ FAU - Martinez-Lara, Esther AU - Martinez-Lara E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20111215 PL - United States TA - J Appl Physiol (1985) JT - Journal of applied physiology (Bethesda, Md. : 1985) JID - 8502536 RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (Beclin-1) RN - 0 (Becn1 protein, mouse) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Poly(ADP-ribose) Polymerase Inhibitors) RN - 0 (Reactive Oxygen Species) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 2.4.2.30 (Poly(ADP-ribose) Polymerases) RN - V55S2QJN2X (NG-Nitroarginine Methyl Ester) SB - IM MH - Altitude MH - Animals MH - Apoptosis Regulatory Proteins/metabolism MH - Beclin-1 MH - Cerebral Cortex/drug effects/metabolism/physiopathology MH - Hypoxia/*metabolism/physiopathology MH - Hypoxia-Inducible Factor 1/*metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - NG-Nitroarginine Methyl Ester/pharmacology MH - Nitric Oxide/antagonists & inhibitors/*metabolism MH - Nitric Oxide Synthase/metabolism MH - Poly(ADP-ribose) Polymerase Inhibitors MH - Poly(ADP-ribose) Polymerases/*metabolism MH - Reactive Oxygen Species/metabolism EDAT- 2011/12/17 06:00 MHDA- 2012/09/12 06:00 CRDT- 2011/12/17 06:00 PHST- 2011/12/17 06:00 [entrez] PHST- 2011/12/17 06:00 [pubmed] PHST- 2012/09/12 06:00 [medline] AID - japplphysiol.00898.2011 [pii] AID - 10.1152/japplphysiol.00898.2011 [doi] PST - ppublish SO - J Appl Physiol (1985). 2012 Mar;112(5):816-23. doi: 10.1152/japplphysiol.00898.2011. Epub 2011 Dec 15.